Skip to Main content Skip to Navigation
Journal articles

L’instabilité génomique, paramètre limitant l’efficacité des thérapies ciblées en oncologie

Abstract : Genomic instability is one of the main properties of tumour development, promoting first the acquisition of genetic alterations and thus carcinogenesis. Then, the chronic and anarchic proliferation of cancer cells also supports and contributes to this instability allowing a continuous evolution of the tumour. The accumulation of mutations resulting from that instability contributes to tumour heterogeneity that occurs in a specific environment. The resulting diversity of oncogenic drivers further complicates the characterization of the origin of cancer cells dysfunction and consequently therapeutic decision. However, the consideration of the molecular context in oncology has initiated the development of targeted therapies. Based on the concept of oncogene addiction and synthetic lethality, these new drugs require the characterization and identification of specific tumour biomarkers. Targeted therapies have thus considerably optimized patient management, improving efficiency and quality of life while limiting the side effects observed with conventional chemotherapies. However, despite significant clinical benefits, some major limitations to their administration remain. The study of the current issues related to these new therapeutic molecules is becoming crucial for patient management towards an improvement of personalized medicine.
Document type :
Journal articles
Complete list of metadata

Cited literature [84 references]  Display  Hide  Download
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Monday, October 26, 2020 - 1:32:41 PM
Last modification on : Wednesday, October 20, 2021 - 3:19:35 AM
Long-term archiving on: : Wednesday, January 27, 2021 - 6:49:18 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document



Amandine Billaud, Louise-Marie Chevalier, Mario Campone, Alain Morel, Frédéric Bigot. L’instabilité génomique, paramètre limitant l’efficacité des thérapies ciblées en oncologie. Bulletin du Cancer, John Libbey Eurotext, 2020, S0007-4551 (20), pp.30373-8. ⟨10.1016/j.bulcan.2020.08.010⟩. ⟨inserm-02978363⟩



Record views